close

Strike action from Thursday 27 June to Tuesday 2 July 2024

Junior doctors at The Christie will strike from 7am on Thursday 27 June until 7am on Tuesday 2 July 2024.

We are proactively contacting patients with appointments that may be affected. If you have an appointment on any of these dates, please continue to come to The Christie and our other centres as planned, unless we contact you to tell you otherwise. Please do not call to check if your appointment is still going ahead.

Skip to Content

Help us improve our website

Clinical trials in T-Cell lymphoma

The list below shows The Lymphoma Group's current clinical trials open for recruitment for T-Cell lymphoma patients.

If you would like to know how to access our trials, please see how to contact us.

  • PROCLIPI - A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.
  • SGN35-032 - A phase 2 trial of brentuximab vedotin plus chemotherapy in people with peripheral T-cell lymphoma.
  • StepPharma/STP938 – Testing STP938 in people with T-cell and B-cell lymphomas that has relapsed or is refractory

  • ASTX660-003 – Testing Tolinapant in combination with other drugs in patients with relapsed or refractory PTCL

  • CCS1477 – Testing CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma

With special thanks to the following:

Lymphoma actionCancer Research UKBloodwiseNCRI

For further information on each trial, please visit the Find a trial page on Lymphoma Action’s website.

Last updated: October 2023